Cenna Biosciences, Inc

[On Demand]
Cenna Biosciences, Inc. is a privately-held biopharmaceutical company in La Jolla CA, focused on the discovery and development of novel drugs for the prevention and treatment of Alzheimer’s disease (AD). The Company was founded in 2006 to translate over a decade’s academic research at UC San Diego by the Founders who became independent of UC San Diego in 2011. Disease-modifying therapies for AD are urgently needed. There is a huge and growing market and patient population worldwide and there is no disease-modifying drug available. Cenna has a novel and different proprietary patented technology that arrests the underlying cause of the disease and that addresses previous failures by others. Preclinical studies in progress with IND filings planned within the next 12-18 months. Funding to date by Founders and $21M in NIH grants. The Company is seeking a $7.5M investment to complete pre-clinical studies on its small molecule and peptide drug candidates to IND.
Company Type:
Privately Funded Company
Company Website:
Company HQ State:
Company HQ Country:
United States
Year Founded:
Main Therapeutic Focus:
Lead Product in Development:
Peptide candidate mP8, small molecule candidate A3
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
President and CEO
Cenna Biosciences Inc.